Select a community
All Communities
Home > Community Treatment Reports > Venlafaxine Treatment Report

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Venlafaxine Treatment Report

Brand Names: Effexor XR, Effexor, Venlafaxine XR, Novo-Venlafaxine XR, Viepax, PMS-Venlafaxine XR

What is Venlafaxine? Venlafaxine is an antidepressant in a group of drugs called selective serotonin and norepinephrine reuptake inhibitors (SSNRIs). It affects chemicals in the brain that may become unbalanced and cause depression. It is used to treat major depressive disorder, anxiety, and panic disorder.

See more information, including instructions, precautions, side effects, and interactions.


Dosages

Based on the patients currently taking Venlafaxine.

Top 10 (Show all)

All (Show top 10)

  18.75 mg as needed daily 1 mg daily 37.5 mg daily 25 mg daily 37 mg daily 37.5 mg daily 50 mg daily 75 mcg daily 75 mg daily 78 mg daily 100 mg daily 105 mg daily 110 mg daily 112.5 mg daily 125 mg daily 150 mg daily 175 mg daily 185.5 mg daily 187 mg daily 187.5 mg daily 200 mg daily 220 mg daily 225 mg daily 250 mg daily 275 mg daily 300 mg daily 337.5 mg daily 375 mg daily 400 mg daily 450 mg daily 487.5 mg daily 600 mg daily 750 mg daily 900 mg daily
  1 Number of Patients: 1 14 Number of Patients: 14 1 Number of Patients: 1 1 Number of Patients: 1 5 Number of Patients: 5 1 Number of Patients: 1 69 Number of Patients: 69 6 Number of Patients: 6 1 Number of Patients: 1 207 Number of Patients: 207 1 Number of Patients: 1 17 Number of Patients: 17 1 Number of Patients: 1 1 Number of Patients: 1 10 Number of Patients: 10 1 Number of Patients: 1 270 Number of Patients: 270 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 4 Number of Patients: 4 6 Number of Patients: 6 1 Number of Patients: 1 103 Number of Patients: 103 3 Number of Patients: 3 1 Number of Patients: 1 116 Number of Patients: 116 1 Number of Patients: 1 11 Number of Patients: 11 2 Number of Patients: 2 10 Number of Patients: 10 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Duration

How long current patients have been taking Venlafaxine or how long patients were taking Venlafaxine before stopping.

Currently Taking Venlafaxine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
9
13
29
85
85
196

Stopped Taking Venlafaxine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
25
33
21
30
38
73
Why Patients Stopped Taking Venlafaxine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 83 37% Side effects too severe: 37%
Did not seem to work 68 30% Did not seem to work: 30%
Doctor's advice 62 27% Doctor's advice: 27%
Other 46 20% Other: 20%
Expense 25 11% Expense: 11%
Personal research 8 4% Personal research: 4%
Course of treatment ended 8 4% Course of treatment ended: 4%
Not indicated 4 2% Not indicated: 2%

Patient Reported Evaluations

Results from 202 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Major 43% 24
Moderate 32% 18
Slight 7% 4
None 7% 4
Can't tell 11% 6

Treat my mood condition(s)

Side-effects (as an overall problem)

Severe 12% 25
Moderate 26% 52
Mild 30% 60
None 32% 65

Top reported side-effects include: Weight gain, Agitation/restlessness, Drowsiness

Summary results are based on 202 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (2 of 202)

  • sumbutterfly
    Pain: All
    Fatigue: Most
    Sleep: All
    Stiffness: All
    function: Most
    external_stress: Little
    Stickman: all
    Description:
    FM:3y Dx
  • sumbutterfly
  • by sumbutterfly
    Mar 01, 2009
  • EfficacyMajor
  • Side-effectsNone
  • Short term memory problems
Advice/Tips
The best thing ever for depression, confusion, memory loss! This is equally as important as Lyrica!

  • jmscout
    Sex: F
    Sensation: None
    Overall: Mild
    Cognition: moderate
    Vision: none
    Speech: none
    Swallowing: none
    Upper limb: moderate
    Walking: moderate
  • jmscout
  • by jmscout
    Aug 22, 2008
  • EfficacyMajor
  • Side-effectsNone
  • Depression

See all evaluation results for Venlafaxine

Report created on November 07, 2009.